Bank of New York Mellon’s Ambit Biosciences Corp AMBI Stock Holding History

Bank of New York Mellon’s Portfolio AMBI Stock Details AMBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-23,955	Closed	-$369K	–	4370
2014 Q3	$369K	Hold	23,955	–	–	﹤0.01%	3723
2014 Q2	$166K	Buy	23,955 +125	+0.5%	+$877	﹤0.01%	3885
2014 Q1	$217K	Buy	23,830 +2,130	+10%	+$22.6K	﹤0.01%	3827
2013 Q4	$209K	Buy	21,700 +9,100	+72%	+$122K	﹤0.01%	3845
2013 Q3	$195K	Buy	+12,600	New	+$167K	﹤0.01%	3803

Bank of New York Mellon's AMBI Position: Q4 2014 in Review

Bank of New York Mellon sold out of Ambit Biosciences Corp (AMBI) in Q4 2014, closing a stake of 23,955 shares — an estimated $369K sold.

Bank of New York Mellon first reported a position in AMBI in Q3 2013 and held it in 5 quarters. The position peaked at $369K in Q3 2014. 0 funds tracked by Wall St. Rank hold AMBI as of Q4 2014.

Bank of New York Mellon reported no remaining Ambit Biosciences Corp position as of Q4 2014 after selling out during the quarter.
Bank of New York Mellon sold 23,955 Ambit Biosciences Corp shares in Q4 2014, an estimated $369K.
Bank of New York Mellon first reported a position in Ambit Biosciences Corp in Q3 2013 and held it in 5 quarters.
Bank of New York Mellon's Ambit Biosciences Corp position peaked at $369K in Q3 2014.
0 funds tracked by Wall St. Rank held Ambit Biosciences Corp as of Q4 2014.

Based on Bank of New York Mellon's 13F filing for Q4 2014, filed 17 Feb 2015.